Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients

被引:77
作者
Kobori, Hiroyuki
Katsurada, Akemi
Ozawa, Yuri
Satou, Ryousuke
Miyata, Kayoko
Hase, Naoki
Suzaki, Yuki
Shoji, Tatsuya
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA
[2] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA
[3] Tulane Univ, Hlth Sci Ctr, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA
[4] Osaka Gen Med Ctr, Osaka, Japan
关键词
IgA nephropathy; angiotensinogen; oxidative stress; angiotensin II; clinical study;
D O I
10.1016/j.bbrc.2007.04.105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study was performed to determine whether immunoreactivity of intrarenal hemeoxygenase-1 and angiotensinogen are increased in IgA nephropathy (IgAN) patients. Hemeoxygenase-1 and angiotensinogen immunoreactivity were determined by immunohistochemistry robot system in renal specimens from 39 patients with IgAN. Normal portions of surgically resected kidney served as controls. IgAN patients showed moderate proteinuria (1.1 +/- 0.2 g/day); however, the control group did not show any proteinuria. Immunoreactivity of intrarenal hemeoxygenase-1 and angiotensinogen in IgAN were significantly increased compared to normal kidneys (2.42 +/- 0.42 vs 1.00 +/- 0.26 for hemeoxygenase-1 and 4.05 +/- 0.40 vs 1.00 +/- 0.21 for angiotensinogen, arbitrary unit). Even though these IgAN patients did not show massive renal damage, hemeoxygenase-1 and angiotensinogen immunoreactivity were increased in these patients at this time point. These data suggest that activated intrarenal reactive oxygen species-angiotensinogen axis plays some roles in development of IgAN at the early stage and will provide supportive foundation of effectiveness of the renin-angiotensin system blockade in IgAN. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 163
页数:8
相关论文
共 54 条
[1]  
ARUOMA OI, 1989, J BIOL CHEM, V264, P20509
[2]   Distinct repair activities of human 7,8-dihydro-8 oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine [J].
Asagoshi, K ;
Yamada, T ;
Terato, H ;
Ohyama, Y ;
Monden, Y ;
Arai, T ;
Nishimura, S ;
Aburatani, H ;
Lindahl, T ;
Ide, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4956-4964
[3]  
Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142
[4]   IgA nephropathy [J].
Barratt, J ;
Feehally, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2088-2097
[5]  
BERGER J, 1968, J UROL NEPHROL, V74, P694
[6]   The incidence of biopsy-proven glomerulonephritis in Australia [J].
Briganti, EM ;
Dowling, J ;
Finlay, M ;
Hill, PA ;
Jones, CL ;
Kincaid-Smith, PS ;
Sinclair, R ;
McNeil, JJ ;
Atkins, RC .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) :1364-1367
[7]   Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein [J].
Brinkmann, MM ;
Glenn, M ;
Rainbow, L ;
Kieser, A ;
Henke-Gendo, C ;
Schulz, TF .
JOURNAL OF VIROLOGY, 2003, 77 (17) :9346-9358
[8]   Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy [J].
Chan, LYY ;
Leung, JCK ;
Tang, SCW ;
Choy, CBY ;
Lai, KN .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08) :2306-2317
[9]   Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy [J].
Dillon, JJ .
SEMINARS IN NEPHROLOGY, 2004, 24 (03) :218-224
[10]  
Dillon JJ, 1997, J AM SOC NEPHROL, V8, P1739